repeat diseases is likely to occur via soluble polyQThese studies suggest that nuclear aggregation is not expanded protein in the nucleus. Ubiquitination of the a causative agent in cell toxicity and identify new candiprotein may not be required for toxicity. If they are reledates for the role of toxic partner to the polyQ expansion.
that does not require their aggregation into nuclear in- Hsp70 homolog, Ssa1; or Hsp104-appeared to disrupt to lead to the production of the toxic fragment. A priori, polyQ aggregates. In sharp contrast, deletion of Hsp104 this fragment could be either the polyQ-containing dohad the unexpected effect of preventing aggregate formain or some other part of the protein. The best evimation, suggesting that the activity of at least this chapdence that the polyQ domain itself is toxic comes from erone may be required for aggregate formation. If aggreexperiments where expression of a small portion of a gates are seeded by the toxic interaction between a disease protein, with a polyQ expansion in the disease disease protein and a cellular target, then the identificarange, is sufficient to cause disease (e.g., Mangiarini et tion of ways to modulate aggregate formation will have al., 1996). Such observations have led to the assumption implications for drug discovery. In Drosophila, a homothat the polyQ-containing fragment is the cause of cellulog of Hdj1 and another J-domain protein (dTPR2) were lar toxicity, but this is not necessarily the case. All such identified as suppressors of polyQ-mediated toxicity experiments have been performed in backgrounds con-(Kazemi-Esfarjani and Benzer, 2000). Importantly, these taining endogenous polyQ protein where the repeat is in two suppressors decreased toxicity but did not dethe wild-type range. If the expressed, polyQ-expanded crease the frequency of aggregate formation. This sugprotein is driving the clipping of endogenous protein, gests that chaperones may interfere with the interaction the putative toxic nonpolyQ fragment could still be probetween the toxic form of the disease protein and its duced. This could explain why toxicity would take so target. Finally, in three different mammalian cell types, long to appear, even in models where the polyQ expanoverexpression of either Hdj1 or Hdj2 suppressed aggresion alone is being expressed to very high levels within gation and toxicity of polyQ-expanded ataxin-3 (Chai et a day of transfection. The rate-limiting step would not al., 1999). be the production of the exogenous, expanded polyQ Thus, chaperones are likely to play at least two roles fragment, but rather the production of a clipped fragin pathogenesis. On one hand, they seem to affect the ment of endogenous polyQ protein. This speculative formation of NIs; this role may be a response to stress model would also explain why each polyQ expansion (Chai et al., 1999) and is likely to be protective. On the disease presents with a different pathology. Toxicity other hand, they may create the very situation that leads derives not from the polyQ moiety that is common to to toxicity. For example, inappropriate association with all eight proteins but from the rest of the protein, unique chaperones could lead to mislocalization of a polyQto each one. The question of whether expression of expanded protein, as the overexpression of chaperones the nonpolyQ protein of a disease can cause diseasesuch as the Hsp40 cognate Ydj1 can cause the mislocalrelated toxicity remains to be addressed. ization of proteins in yeast (Blumberg and Silver, 1991). From the above discussion, it seems likely that polyQ Alternatively, chaperones could stabilize the toxic conformation of the polyQ-expanded protein or be required expansions cause toxicity from the nucleus in a manner both the androgen receptor (the protein mutated in another polyQ expansion disease, SBMA) and htt (Diamond et al., 2000).
In light of the studies discussed here, the model for cellular pathogenesis in polyQ expansion diseases becomes both more complex and more simple (Figure 1 ). Neither ubiquitination nor nuclear aggregate formation appear to contribute to toxicity, simplifying the system considerably. In contrast, the mechanism whereby a toxic portion of the protein may cause disease remains unknown. As previously proposed, the polyQ expansion likely causes the mutant protein to adopt a new conformation that leads to altered interactions with a range of proteins. Some of these proteins, formerly candidates as mediators of toxicity, may not be important to toxicity; these include some chaperones (e.g., Hsp104, apparently required for the formation of nuclear aggregates) and the ubiquitin-dependent proteolytic machinery. ticoid receptor can decrease nuclear aggregation of
